Armistice Capital’s MacroGenics MGNX Stock Holding History

Armistice Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1M	Sell	5,006,752 -1,005,248	-17%	-$3.8M	0.28%	56
2026 Q1	$17.4M	Sell	6,012,000 -312,000	-5%	-$665K	0.31%	65
2025 Q4	$10.2M	Buy	6,324,000 +364,000	+6%	+$572K	0.12%	101
2025 Q3	$10M	Hold	5,960,000	–	–	0.15%	85
2025 Q2	$7.21M	Sell	5,960,000 -336,000	-5%	-$487K	0.12%	83
2025 Q1	$8M	Buy	6,296,000 +20,000	+0.3%	+$52.2K	0.12%	97
2024 Q4	$20.4M	Buy	6,276,000 +18,000	+0.3%	+$64.8K	0.28%	71
2024 Q3	$20.6M	Buy	6,258,000 +258,000	+4%	+$1.01M	0.33%	63
2024 Q2	$25.5M	Buy	6,000,000 +3,600,000	+150%	+$35.1M	0.32%	55
2024 Q1	$35.3M	Sell	2,400,000 -2,172,000	-48%	-$32.8M	0.47%	36
2023 Q4	$44M	Sell	4,572,000 -140,000	-3%	-$968K	0.6%	30
2023 Q3	$22M	Sell	4,712,000 -888,000	-16%	-$4.42M	0.34%	53
2023 Q2	$30M	Sell	5,600,000 -360,000	-6%	-$2.22M	0.43%	48
2023 Q1	$42.7M	Sell	5,960,000 -132,000	-2%	-$795K	0.62%	38
2022 Q4	$40.9M	Sell	6,092,000 -36,000	-0.6%	-$197K	0.71%	34
2022 Q3	$21.2M	Hold	6,128,000	–	–	0.37%	57
2022 Q2	$18.1M	Buy	6,128,000 +1,128,000	+23%	+$5.93M	0.32%	65
2022 Q1	$44M	Buy	5,000,000 +2,300,000	+85%	+$25.4M	0.85%	36
2021 Q4	$43.3M	Buy	+2,700,000	New	+$50.8M	0.71%	38

Other funds holding MGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital's MGNX Position: Q2 2026 in Review

Armistice Capital reduced its MacroGenics (MGNX) stake by 17% in Q2 2026, selling an estimated $3.8M and leaving 5,006,752 shares worth $23.1M. The position accounts for 0.28% of the portfolio, ranked #56.

Armistice Capital first reported a position in MGNX in Q4 2021 and has held it in 19 quarters since. The position peaked at $44M in Q1 2022. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Armistice Capital held 5,006,752 shares of MacroGenics worth $23.1M as of Q2 2026.
Armistice Capital sold 1,005,248 MacroGenics shares in Q2 2026, an estimated $3.8M.
MacroGenics made up 0.28% of Armistice Capital's portfolio in Q2 2026, its #56 holding.
Armistice Capital first reported a position in MacroGenics in Q4 2021 and has held it in 19 quarters since.
Armistice Capital's MacroGenics position peaked at $44M in Q1 2022.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.